The aim of the study was to investigate the role of glutamate residue 113 in transmembrane domain 2 of the human noradrenaline transporter in determining cell surface expression and functional activity. This residue is absolutely conserved in all members of the Na + -and Cl --dependent transporter family.
The noradrenaline transporter (NET), which is also known as uptake 1 (Iversen 1967) , is responsible for reuptake into noradrenergic neurons of synaptically released noradrenaline, and it is a target for psychoactive drugs. In addition to the endogenous catecholamines, noradrenaline, dopamine and adrenaline, the NET also transports indirectly acting amines such as tyramine and the psychostimulant amphetamine, as well as a variety of other compounds including the dopaminergic neurotoxin MPP + (Graefe and Bö nisch 1988; Bö nisch and Brü ss 1994) . The NET is inhibited selectively, with nanomolar affinity, by nisoxetine and the tricyclic antidepressant desipramine, which in their tritiated form have been used to label the NET protein, and is less selectively inhibited by cocaine (Bö nisch and Harder 1986; Schö mig et al. 1988; Tejani-Butt et al. 1990) . From the number of transporter sites estimated from inhibitor binding and from the maximal transport rate of noradrenaline, the turnover number can be estimated (Bö nisch and Harder 1986; Bö nisch 1998) . Substrate transport as well as inhibitor binding have been shown to be absolutely dependent on Na + and Cl -ions, and it has been proposed that these two ions are cotransported together with amine substrates (Sammet and Graefe 1979; Friedrich and Bö nisch 1986; Graefe and Bö nisch 1988) .
The human NET (hNET) was the first NET to be cloned (Pacholczyk et al. 1991) and subsequently those of other species have been cloned, including the bovine and rat NETs (Lingen et al. 1994; Brüss et al. 1997) . The NET is a member of the subfamily of monoamine neurotransmitter transporters in the superfamily of Na + -and Cl --dependent transporters for neurotransmitters and certain amino acids. The topology of this family of membrane proteins is characterized by 12 putative transmembrane domains (TMDs), a large extracellular loop and cytoplasmic amino and carboxyl termini (Bö nisch and Brü ss 1994; Amara and Sonders 1998; Hoffman et al. 1998) . The NET shows a high degree of identity or homology to the dopamine transporter (DAT), the serotonin transporter (SERT) and the GABA transporter (GAT-1) (Hoffman et al. 1998) .
Chimera studies of DAT and NET (Giros et al. 1994; Buck and Amara 1995; Syringas et al. 2000) , and of SERT and NET (Blakely et al. 1993; Barker et al. 1994 ) have identified functional domains within the monoamine transporter proteins. Amino acids within a highly conserved region in TMD 1 of the Na + -and Cl --dependent neurotransmitter transporters have been identified as being critically involved in ligand binding and substrate transport (Borowsky and Hoffman 1995; Masson et al. 1999) . In a recent study, residues in TMDs 6-8 of the hNET were shown to interact with tricyclic antidepressants, since their exchange for the corresponding amino acids of the tricyclic antidepressant-insensitive DAT caused marked decreases in the affinities of these inhibitors to the mutant NETs (Roubert et al. 2001a) .
The aim of the present study was to investigate the role of the glutamate residue 113 in TMD 2 of the hNET, close to the beginning of the first intracellular loop, by investigating the effects of changes in size, charge and polarity of this residue in terms of cell surface expression, cellular localization and functional activity of the mutant NETs. This glutamate residue is absolutely conserved in all known members of the family of Na + -and Cl --dependent transporters for neurotransmitters and amino acids such as proline, betaine, taurine and creatine (Table 1) , indicating a potentially crucial role of this residue in expression and/or function of these transporters. For the rat GAT-1, this residue has been proposed to be involved in Na + binding (Keshet et al. 1995) .
Mutations of this glutamate residue to aspartate (hE113D mutant), alanine (hE113A mutant) and glutamine (hE113Q mutant) were made, and the effects of the mutations were investigated by confocal laser scanning microscopy (using EGFP-tagged transporters), substrate transport and inhibitor binding. We show that mutation of the 113 glutamate residue to glutamine has only minor functional consequences, whereas mutation to alanine or aspartate causes a strong reduction in surface expression and function of the mutated transporter.
Materials and methods

Construction of hNET mutants
Mutagenesis PCR was carried out using the QuikChange SiteDirected Mutagenesis Kit (Stratagene Cloning Systems, La Jolla, CA, USA) with hNET (in pEUK-C1 or pEGFP-C1 vectors, donated by Professor S. Amara, Vollum Institute, Portland, OR, USA) as template and pfu Turbo DNA polymerase (Stratagene) to produce mutant cDNAs. Sense and antisense custom oligonucleotides (Sigma-Aldrich, Sydney, New South Wales, Australia) were designed to contain the desired mutations, and the sequences of the sense strands (with mutations indicated in underlined bold) were: hE113A 5¢-CTGTTCTACATGGCGCTGGCTCTGGG-3¢; hE113D 5¢-CTGTTCTACATGGATCTGGCTCTGGG-3¢ and hE113Q 5¢-CTGTTCTACATGCAGCTGGCTCTGGG-3¢. Dpn I (Stratagene) was used to digest the parental hNET cDNA, and XL1-blue supercompetent Escherichia coli were transformed with the mutant cDNA in the pEUK-C1 or pEGFP-C1 vector. Plasmid preparations were carried out using the Concert High Purity Midiprep System (Invitrogen Australia Pty Ltd, Melbourne, Victoria, Australia) to produce sufficient quantities of high purity cDNA for transient and stable transfections of cells (see below). To confirm the mutations, the cDNA samples were automatically sequenced over the region including the mutated base, using the Big-Dye Terminator Ready Reaction Mixture kit (Applied Biosystems, Melbourne, Vic, Australia) and custom synthesized sequencing primers (SigmaAldrich) with hNET included as a control. DyeEx Spin Kit clean-up columns (Qiagen Pty Ltd, Clifton Hill, Victoria, Australia) were used to purify the samples prior to sequencing. Automatic sequencing was performed by the Australian Genome Research Facility (The University of Queensland, Brisbane, Queensland, Australia).
Cell culture and transfection COS-7 (SV40-transformed African green monkey kidney cells; American Type Culture Collection, Bethesda, MD, USA) and HEK-293 cells (human embryonic kidney cells; American Type Culture Collection) were grown at 37°C in a 5% CO 2 , humidified atmosphere on standard plastic cultureware in either Dulbecco's modified Eagle's medium (DMEM; Invitrogen) for COS-7 cells or DMEM/F12 (Invitrogen) for HEK-293 cells, both supplemented with 10% fetal calf serum (Invitrogen) and 100 units/mL penicillin and 100 lg/mL streptomycin (Invitrogen) to obtain complete medium. COS-7 cells were subcultured onto 12-well culture plates and transiently transfected with hNET or mutant cDNA, using Lipofectamine (Invitrogen) as previously described (Paczkowski et al. 1999) . The experiments were performed 48 h following the transfection.
HEK-293 cells were subcultured onto 60 mm culture dishes, and stably transfected according to the procedure used for transient transfection of COS-7 cells. After 48 h, the stably transfected cells were selected by addition of 800 lg/mL Geneticin (G418, Invitrogen) to complete DMEM/F12 for 10 days. The selection pressure for stable transfectants was then maintained by the subsequent use of medium containing 250 lg/mL G418. The cells were subcultured, 3 days prior to confocal microscopy, onto 18 mm diameter cover slips coated with poly-L-ornithine. On the day of microscopy, the cells were fixed with 4% paraformaldehyde (pH 7.4) for 30 min, ]nisoxetine (0.5-60 nM) in the absence or presence of 200 lM dopamine (to determine non-specific binding) and other drugs as necessary. In Na + ion replacement experiments, the NaCl concentration of the Krebs/HEPES buffer was changed, so that for controls 150 mM NaCl was present and, for other wells in the experiment, up to 140 mM of this NaCl was replaced by an equiosmolar concentration of LiCl or N-methyl-D-glucamine (NMDG). Immediately after the incubation period in all experiments, the cells were washed three times with 2 mL Krebs/HEPES buffer at 0°C and lysed by addition of 750 lL of 0.1% Triton-X100 in 10 mM Tris-HCl (pH 7.5).
Binding of [
3 H]desipramine to the NET on crude plasma membranes was carried out essentially as described previously (Bönisch and Harder 1986) . For the isolation of plasma membranes, transfected cells were collected by centrifugation at 180 g (10 min at 4°C), resuspended in 2 mL of 50 mM HEPES/NaOH buffer (pH 7.4) and then homogenized (twice for 5 s) in a Polytron homogenizer. The homogenizer was washed with 2 mL buffer and the combined suspension was centrifuged for 20 min at 4°C at 40 000 g. The pellet was resuspended in 4 mL buffer and again centrifuged as described above. The final pellet containing the crude plasma membranes was resuspended in 1 mL buffer and stored in aliquots at ) 20°C until use. For binding experiments, plasma membranes (25 lL; 0.5 mg/mL protein in 50 mM HEPES/NaOH buffer, pH 7.4) were incubated at 25°C for 30 min with [ ] in a total volume of 250 lL. Buffer A at 0°C was then added (1 mL) and the mixture was filtered through polyethyleneimine (0.5%)-pretreated GF/F glass fiber filters which were then washed twice with 1 mL of incubation buffer at 0°C. Nonspecific binding was determined in the presence of 10 lM nisoxetine.
The 3 H content of the cell lysates and of the GF/F filters was determined in a 2500 TR Packard Liquid Scintillation Analyzer. Protein was measured according to the Lowry method (Lowry et al. 1951 ) using bovine serum albumin as standard.
Uptake assays
Culture medium was removed from the COS-7 or HEK-293 cells, and they were then washed twice with 1 mL Krebs/HEPES buffer containing 0.1% bovine serum albumin at 37°C. The cells were incubated for 15 min at 37°C with 1 mL Krebs/HEPES buffer containing 0.1% bovine serum albumin in the absence or presence of 1 lM nisoxetine (to determine non-specific uptake) and other drugs as appropriate, and [ . Arithmetic means ± SEM or geometric means and 95% confidence limits of uptake and binding data or kinetic parameters were calculated as indicated in Results. Values for binding and uptake of the mutants were compared with zero using the Student's t-test (INSTAT 3; GraphPad). The significance of differences between values for hNET and the mutants was determined by paired or unpaired t-tests or one factor ANOVA followed by Tukey's post-hoc t-tests (PRISM 3) on absolute or log data as indicated in Results. Two factor ANOVA was used to analyse the effects of NaCl replacement by LiCl and NMDG and was followed by one factor ANOVA and Tukey's post-hoc t-tests for those factors that showed significant variation (PRISM 3).
Materials
The drugs used in the study were: cocaine hydrochloride (Drug Houses of Australia, Sydney, New South Wales, Australia), desipramine hydrochloride (Sigma-Aldrich), dopamine hydrochloride (Sigma-Aldrich), Fig. 1 and some of the data in Table 2 Stock solutions of noradrenaline (10 mM) and dopamine (100 mM) were prepared in 10 mM HCl, and stock solutions of U-0521 (1 mM) and all other drugs (10 mM) were prepared in water. All dilutions were prepared on the day of the experiment in Krebs/ HEPES buffer containing 0.1% bovine serum albumin.
Results
Expression, function and localization of hNET and mutants
The cDNAs of three hNET mutants, in which glutamate 113 was replaced by either alanine (hE113A), aspartate (hE113D) or glutamine (hE113Q), were prepared by site-directed mutagenesis, and their sequences were confirmed by automatic sequencing. In the first series of experiments, surface expression of the mutant transporters was examined by measuring the specific binding of the selective NET inhibitor [ 3 H]nisoxetine (0.5 nM) in intact COS-7 cells transiently transfected with hNET or mutant cDNA. As shown in Fig. 1(a) , the mutants hE113D and hE113Q showed a lower specific nisoxetine binding than the hNET, and the hE113A mutant showed very low binding which, nevertheless, was significantly different from zero (p < 0.05). These data indicate that the mutant transporters are expressed to some degree at the cell surface. To determine noradrenaline transport activity, COS-7 cells transiently expressing the hNET or the mutants were incubated with 10 nM [ 3 H]noradrenaline and specific noradrenaline uptake was measured. For the mutants hE113A and hE113D, noradrenaline uptake was not significantly different from zero (p > 0.05), whereas the hE113Q mutant showed about 50% of the noradrenaline uptake observed in the wild-type hNET (Fig. 1b) . Hence, noradrenaline uptake was further examined only for the hE113Q mutant (see below).
HEK-293 cells stably expressing hNET-EGFP or the EGFP-tagged mutants were examined by confocal laser scanning microscopy for cellular distribution of the ]noradrenaline (10 nM, 37°C, 2 min) was determined as the difference between uptake in the absence and presence of 1 lM nisoxetine (n ¼ 12 for hNET; n ¼ 4-6 for the mutants). The data were analysed by one factor ANOVA followed by Tukey's post-hoc t-tests compared with hNET. ***p < 0.001, significantly different from hNET. expressed transporter proteins. These cells showed the same pattern of [ 3 H]noradrenaline uptake (data not shown) as that described above (Fig. 1b) for cells transiently expressing non-tagged transporters. Expression of the wild-type hNET-EGFP and the hE113Q-EGFP mutant was targeted to the plasma membrane (Fig. 2) . There was little expression of the hE113A-EGFP mutant and it was not specifically targeted to the plasma membrane (Fig. 2) , and the hE113D-EGFP mutant showed marked intracellular expression (Fig. 2) (Fig. 3a) and MPP + (Fig. 3b) , and K i values were calculated from the curves for all of the inhibitors and substrates (Table 3) . Compared with the wild-type hNET, the K i values of cocaine were increased for both the hE113D and the hE113Q mutant, whereas those of desipramine were decreased for the hE113D mutant and were unchanged for the hE113Q mutant ( Table 3) .
As illustrated for MPP + in Fig. 3(b) , the curves for inhibition of [ 3 H]nisoxetine binding by substrates showed a shift to higher concentrations for the hE113D mutant compared with the wild-type hNET and a decrease in the maximal inhibition for the hE113Q mutant to 80% for noradrenaline, 67% for dopamine and 64% for MPP + . Compared with the K i values for the wild-type hNET, the K i values of noradrenaline, dopamine and MPP + showed no changes for the hE113Q mutant, but were increased 82-to 260-fold for the E113D mutant ( Table 3) .
Because of the pronounced change in the K i values of substrates for the hE113D mutant, an additional series of experiments was carried out using another radioligand, Noradrenaline transporter: role of glutamate 113 349 (n ¼ 5), respectively. In agreement with the data obtained with nisoxetine in intact cells, the hE113D mutant had a significantly lower K D (p < 0.01) and a significantly lower B max (p < 0.001; Student's t-test) of desipramine binding, compared with the wild-type hNET. For the hE113D mutant, the K i value of noradrenaline for inhibition of desipramine binding (377 lM, 95% confidence limits: 266, 535 lM, n ¼ 6) was significantly greater (p < 0.001; Student's t-test) by 9.4-fold than that for the wild-type hNET (40 lM, 95% confidence limits: 15, 108 lM, n ¼ 5). These K i values of noradrenaline for inhibition of desipramine binding to the isolated plasma membranes were markedly greater than those for inhibition of nisoxetine binding to intact cells (Table 3) . (Fig. 4a) or NMDG (Fig. 4b) (Table 4) . When NaCl was replaced by NMDG hydrochloride, the wild-type hNET and the hE113Q mutant, but not the hE113D mutant, exhibited lower EC 50 values of Na + than when NaCl was substituted by LiCl (Table 4) . For the hE113D mutant, the EC 50 as well as the E max values of Na + were two-to threefold less than those for the wild-type hNET (Table 4) . For the hE113Q mutant, the EC 50 values of Na + were not significantly different from those for the wild-type hNET, whereas the E max values were decreased compared with hNET ( (Table 2) , the turnover number, i.e. the number of transport cycles per carrier and unit of time, was calculated (Bö nisch and Harder 1986) . This V max /B max ratio was 108 and 51 min )1 for the hNET and the hE113Q mutant, respectively. (Cheng and Prusoff 1973) . The log K i values for hNET and the mutants were compared by one factor ANOVA followed by Tukey's post-hoc t-tests. **p < 0.01, ***p < 0.001, significantly different from hNET. This indicates that replacement of glutamate by glutamine causes a reduction in the turnover number by a factor of 2.
Na
K i values for inhibition of [ 3 H]noradrenaline uptake Inhibition of [
3 H]noradrenaline uptake by the inhibitors cocaine, nisoxetine and desipramine was investigated in four experiments in COS-7 cells transiently transfected with the cDNA of the wild-type hNET or the hE113Q mutant. The K i values (in nM; geometric means with 95% confidence limits) for cocaine, nisoxetine and desipramine were 304 (234, 393), 4.9 (4.0, 6.1) and 6.7 (5.2, 8.6), respectively, for the wild-type hNET and 229 (198, 266), 4.3 (3.8, 5 .0) and 5.1 (4.2, 6.2), respectively, for the hE113Q mutant. The only significant (p < 0.05) change was a 1.3-fold decrease in the K i value of desipramine for the hE113Q mutant compared with the wild-type hNET.
Discussion
We have examined the functional and pharmacological importance of the glutamate residue 113 in the hNET. This glutamate residue is absolutely conserved in the family of Na + -and Cl --dependent transporters for monoamines, GABA, glycine, proline, betaine, taurine and creatine (Table 1 ). The glutamate 113 residue was mutated to alanine, glutamine or aspartate. Each of these mutations had different effects on the expression and pharmacological properties of the NET.
Compared with the wild-type hNET, the hE113A mutant displayed a very low level of plasma membrane expression, as indicated by the very low B max of [ 3 H]nisoxetine binding to intact cells and also a marked decrease in its affinity for nisoxetine. Nisoxetine binding to intact cells has previously been shown to reflect cell surface expression of the NET (Apparsundaram et al. 1998) . The low surface expression of the hE113A mutant is supported by confocal microscopy which shows that this mutant is not specifically targeted to the plasma membrane. A mutation from glutamate to alanine induces a large decrease in size and a loss of charge and polarity of the residue. A study of a large number of proteins for amino acid composition and their solvent accessibility showed a positive correlation between amino acids that have similar preference for solvent contacts and local environment (Fig. 4) were calculated by non-linear regression analysis to obtain the kinetic parameters. Two factor ANOVA showed that the mutations had a significant effect on both log EC 50 and E max values (p < 0.001), so the mutants were compared with hNET by one factor repeated measures ANOVA, followed by Tukey's post-hoc t-tests: *p < 0.05, **p < 0.01, ***p < 0.001, significantly different from hNET. Only the log EC 50 values showed differing effects between the replacement ions (p < 0.001), so the log EC 50 values for NMDG were compared with Li + by paired t-test: p < 0.01, significantly different from the corresponding value for Li + replacement. Table 4 .
Noradrenaline transporter: role of glutamate 113 351 because of similar trends in their distribution (Jonson and Petersen 2001) . In the latter study, alanine shows a high negative correlation with all except the non-polar residues. Thus, the substitution of the positively charged glutamate by the non-polar alanine may be responsible for incorrect protein folding. This in turn may have caused the defective trafficking to the plasma membrane with a complete loss of transport function of the hE113A mutant. The hE113Q mutant was the only one of the three investigated NET mutants to show properties similar to those of the wild-type hNET. This mutant showed the same K m values for noradrenaline and dopamine and the same K i values for inhibition of [ One speculative explanation could be that hE113Q is expressed in two conformations, both with the same affinities for inhibitors, but only one conformation having affinity for substrates.
In agreement with confocal microscopy of the EGFPtagged hE113Q mutant, the maximum binding (B max ) of [ 3 H]nisoxetine to this transporter mutant was about the same as for the wild-type hNET, indicating largely unchanged surface expression. However, since the V max of noradrenaline uptake reached only 40-50% of that of the wild-type hNET, the turnover number (i.e. the number of transport cycles per transporter per unit of time) as calculated from the ratio V max / B max (Bö nisch and Harder 1986) , was only about half that of the wild-type hNET. The wild-type hNET had a turnover number of 108 min )1 which is close to the value previously described for the rat NET in PC12 cells (Bö nisch and Harder 1986) . The reduced turnover number in the hE113Q mutant indicates that the mutation lowered the velocity of the conformational changes of substrate-loaded or unloaded carrier during a transport cycle or could be accounted for by the expression of two forms of the hE113Q mutant as suggested above, only one of which has affinity for and transports substrates. Since the EC 50 of the cosubstrate Na + for stimulation of nisoxetine binding was not changed in the hE113Q mutant, the slower substrate translocation was not due to a change in the affinity of the hE113Q mutant for Na + . The lower E max for the stimulatory effect of Na + at the hE113Q mutant is correlated with the lower V max of noradrenaline uptake of this mutant. Thus, although the mutation of glutamate to glutamine causes a loss of charge (with little change in the size of the residue), the functional consequences were not very pronounced. This is compatible with the observation that glutamate and glutamine residues have similar preference for solvent contacts (Jonson and Petersen 2001) . However, these results for the hNET are different from those described for a mutation of the analogous, conserved glutamate 101 in the rat GAT-1 to glutamine. The lack of GABA transport by rat GAT-1 mutant has been proposed to be due to a defect in Na + binding (Keshet et al. 1995) , but the data obtained in the present study for hNET provide no support for this proposal, suggesting that either this glutamate residue is not involved in Na + binding or that the Na + binding sites are different for the NETs and GATs.
The mutation of glutamate 113 in the hNET to aspartate (hE113D) had much more pronounced effects than the mutation to glutamine (hE113Q). The marked functional changes evoked by the mutation to aspartate are compatible with the idea that this amino acid exchange is not a conservative exchange. This assumption is confirmed by recent findings that, although these two amino acids differ only by one methylene group, they have very different spatial preferences (Jonson and Petersen 2001) . In addition, aspartic acid has been shown to favour interactions between the side chain carbonyl group and the backbone carbonyl group resulting in a ring-like structure which is not observed for glutamic acid (Deane et al. 1999) .
The hE113D mutant showed a reduction in indicating a marked reduction in cell surface expression of the hE113D mutant. This reduction agrees with confocal microscopy which shows no specific targeting of the hE113D mutant to the plasma membrane. The hE113D mutant showed a decreased K D for nisoxetine binding, indicating that the affinity of nisoxetine was increased. An increase in the affinity was also observed for desipramine but not for cocaine, of which the affinity was lower for the mutant transporter than for the wild-type hNET. The parallel changes in the affinities of nisoxetine and the tricyclic antidepressant desipramine for the hNET mutant are consistent with the idea that the binding sites of the hNET for these two inhibitors are identical or overlapping. However, as shown recently (Roubert et al. 2001a) , the desipramine binding sites are different from that for cocaine.
The most obvious functional changes observed in the hE113D variant were the pronounced decreases in the substrate affinities. Compared with the wild-type hNET, the affinities for the substrates dopamine, MPP + and noradrenaline (measured as 1/K i for inhibition of nisoxetine binding to intact cells) were decreased by a factor of 82, 132 and 260, respectively. However, for isolated plasma membranes the hE113D mutant showed only a nine-fold decrease in the affinity of noradrenaline (determined from the K i for inhibition of [ 3 H]desipramine binding) compared with the wild-type hNET. The reason for the pronounced shift of substrate affinity in intact cells compared with that seen in isolated plasma membranes has not been established. In intact cells transfected with the wild-type hNET, substrate affinities were markedly higher (lower K i values) than those obtained with isolated plasma membranes. Thus, while in intact cells the K i value of noradrenaline for inhibition of inhibitor binding was in the nanomolar range (78 nM) and lower than the K m of noradrenaline transport (1.9 lM), in isolated plasma membranes K i values for inhibition of NET inhibitor binding were in the micromolar range and greater than the K m of noradrenaline transport from both the present study and previous reports (Bö nisch and Harder 1986; Schö mig et al. 1988; Tejani-Butt et al. 1990 ). In agreement with the results of the present study, K i values of dopamine for inhibition of radioligand binding to DAT in intact cells have also recently been reported to be markedly lower than K m values for dopamine transport (Lin et al. 2000a, b) . Thus, high affinity binding of substrates to monoamine transporters has been observed only in intact cells, indicating that a different conformation of the transporters, and possibly a high affinity state for substrates, exists in intact cells compared with dispersed cell membranes. This could be due to an interaction of transporters in intact cells with PDZ domain-containing proteins such as PICK1 (Torres et al. 2001) or to an increased formation of oligomeric structures (De Felice and Adams 2001) .
Low surface expression of the hE113D mutant could have contributed to a lack of noradrenaline uptake by the hE113D mutant. Na + is absolutely required for binding of NET inhibitors such as nisoxetine and desipramine (Bö nisch and Harder 1986; Tejani-Butt et al. 1990 ) and for binding and transport of substrates (Graefe and Bö nisch 1988) . We previously determined the EC 50 of Na + for stimulation of noradrenaline uptake (Paczkowski et al. 1999 ) and the value was very similar to that obtained in the present study for stimulation of nisoxetine binding. For the hE113D mutant in the present study, the increase in the apparent affinity of Na + (as shown by the 2-3.2-fold lower EC 50 for stimulation of nisoxetine binding by Na + ) would be expected to lower the transport rate for noradrenaline since it should slow the intracellular dissociation of cotransported Na + from its binding site at the NET and thereby reduce the turnover number. The glutamate residue (113 in the hNET) in TMD 2 is absolutely conserved among all known Na + -and Cl --dependent transporters ( Table 1 ), indicating that it has an important role in the common properties of these transporters. Due to its critical localization at the lipid bilayer border, it could be crucially involved in the gating during substrate and/or cosubstrate transport which is expected to be highly affected by conformational rearrangements of the transporter protein. It is possible that glutamate 113 in the hNET (or glutamine in the hE113Q mutant) may be exposed for interaction with substrate during translocation by a conformational change of the NET, but that this change may not be possible when the aspartate residue (hE113D) is present instead.
Taken together, the results of the study show that glutamate 113 in the hNET is an essential amino acid for the surface expression and function of this transporter. Expression and function of the hNET were not markedly affected if glutamate was replaced by glutamine, whereas a mutation to aspartate (in hE113D) resulted in pronounced functional changes. The size and obviously not the charge of this residue, which is at the transition of TMD 2 to the first intracellular loop and is absolutely conserved in this transporter family, seems to be the most critical factor for maintenance of its function and surface expression.
